Strata Critical Medical, Inc.

Strata Critical Medical, Inc. (ticker: BLDE) submitted an 8-K current report to the U.S. Securities and Exchange Commission on December 15, 2020, disclosing a material corporate development during the blank-check vehicle's active lifecycle. The special purpose acquisition company is categorized within the healthcare and medical technology sector, consistent with its stated corporate focus on critical medical applications. The 2020 filing, bearing accession number 0001104659-20-135523, represents one of several key SEC disclosures marking the SPAC's progress during that period. Analysts and investors researching BLDE's deal history, sponsor background, and complete filing record can access the full dataset by signing up at SpacDesk.